Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DSM-Firmenich Biomedical is a global leader in biomaterials science and regenerative medicine, providing innovative materials and technologies to medical device and pharmaceutical companies. The company specializes in developing and manufacturing high-performance polymers, bioceramics, and collagen-based solutions used in applications ranging from orthopedic implants to drug delivery systems. As a key partner in the healthcare industry, they offer contract development and manufacturing services (CDMO) to help clients bring advanced medical solutions to market. Their portfolio includes proprietary technologies like Dyneema Purity fiber and various bioresorbable polymers designed to improve patient outcomes.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DSM-Firmenich Biomedical.